Search Results Search Sort by RelevanceMost Recent Medicine and Society May 2009 The Business of Healing, Then and Now Daniel N. Robinson, PhD The healer’s professional role and socioeconomic status from ancient to modern times. Virtual Mentor. 2009;11(5):399-401. doi: 10.1001/virtualmentor.2009.11.5.msoc1-0905. Health Law May 2009 Splitting Fees or Splitting Hairs? Cheryl Miller, JD The Office of Inspector General’s (OIG) prohibits physician fee-splitting; an Illinois bill attempts to carve out an exception to the OIG ban. Virtual Mentor. 2009;11(5):387-389. doi: 10.1001/virtualmentor.2009.11.5.hlaw1-0905. Health Law Sep 2009 A Physician's Duty to Warn Third Parties of Hereditary Risk Kristin E. Schleiter, JD, LLM Two key court decisions came to different conclusions regarding physicians’ duty to warn third parties of genetic risk. Virtual Mentor. 2009;11(9):697-700. doi: 10.1001/virtualmentor.2009.11.9.hlaw1-0909. State of the Art and Science Jul 2004 Diagnosing Anabolic Steroid Use Audiey C. Kao, MD, PhD Physicians should look for specific clinical evidence when examining a patient suspected of anabolic steroid use. Virtual Mentor. 2004;6(7):316-317. doi: 10.1001/virtualmentor.2004.6.7.cprl1-0407 In the Literature Aug 2004 Ethical Issues in the Application and Prescription of CNS Interventions Abraham P. Schwab, PhD A neuroscientist and a sociologist discuss the ethical concerns with common neurological medicines that are used to enhance or change behavior. Virtual Mentor. 2004;6(8):347-349. doi: 10.1001/virtualmentor.2004.6.8.jdsc1-0408. Case and Commentary Apr 2004 Retainer Practice: Scientific, Social Justice, and Ethical Perspectives Martin T. Donohoe, MD, FACP Retainer practices set an example to medical students and other providers that the highest level of physician satisfaction is available only to those who serve the wealthy. Virtual Mentor. 2004;6(4):166-170. doi: 10.1001/virtualmentor.2004.6.4.ccas4-0404. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Viewpoint Aug 2004 Cosmetic Neurology: For Physicians the Future is Now Anjan Chatterjee, MD Medications for brain enhancement raise many ethical concerns regarding the roles of personal autonomy and responsibility. Virtual Mentor. 2004;6(8):367-371. doi: 10.1001/virtualmentor.2004.6.8.oped1-0408. Pagination First page « First Previous page ‹ Previous … Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Current page 10 Page 11 Next page Next › Last page Last »
Medicine and Society May 2009 The Business of Healing, Then and Now Daniel N. Robinson, PhD The healer’s professional role and socioeconomic status from ancient to modern times. Virtual Mentor. 2009;11(5):399-401. doi: 10.1001/virtualmentor.2009.11.5.msoc1-0905.
Health Law May 2009 Splitting Fees or Splitting Hairs? Cheryl Miller, JD The Office of Inspector General’s (OIG) prohibits physician fee-splitting; an Illinois bill attempts to carve out an exception to the OIG ban. Virtual Mentor. 2009;11(5):387-389. doi: 10.1001/virtualmentor.2009.11.5.hlaw1-0905.
Health Law Sep 2009 A Physician's Duty to Warn Third Parties of Hereditary Risk Kristin E. Schleiter, JD, LLM Two key court decisions came to different conclusions regarding physicians’ duty to warn third parties of genetic risk. Virtual Mentor. 2009;11(9):697-700. doi: 10.1001/virtualmentor.2009.11.9.hlaw1-0909.
State of the Art and Science Jul 2004 Diagnosing Anabolic Steroid Use Audiey C. Kao, MD, PhD Physicians should look for specific clinical evidence when examining a patient suspected of anabolic steroid use. Virtual Mentor. 2004;6(7):316-317. doi: 10.1001/virtualmentor.2004.6.7.cprl1-0407
In the Literature Aug 2004 Ethical Issues in the Application and Prescription of CNS Interventions Abraham P. Schwab, PhD A neuroscientist and a sociologist discuss the ethical concerns with common neurological medicines that are used to enhance or change behavior. Virtual Mentor. 2004;6(8):347-349. doi: 10.1001/virtualmentor.2004.6.8.jdsc1-0408.
Case and Commentary Apr 2004 Retainer Practice: Scientific, Social Justice, and Ethical Perspectives Martin T. Donohoe, MD, FACP Retainer practices set an example to medical students and other providers that the highest level of physician satisfaction is available only to those who serve the wealthy. Virtual Mentor. 2004;6(4):166-170. doi: 10.1001/virtualmentor.2004.6.4.ccas4-0404.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Physicians have an ethical obligation to warn athletes about the potential health problems associated with performance-enhancing drugs. Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Viewpoint Aug 2004 Cosmetic Neurology: For Physicians the Future is Now Anjan Chatterjee, MD Medications for brain enhancement raise many ethical concerns regarding the roles of personal autonomy and responsibility. Virtual Mentor. 2004;6(8):367-371. doi: 10.1001/virtualmentor.2004.6.8.oped1-0408.